Back
Halozyme Therapeutics, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
66
HALO
Halozyme Therapeutics, Inc.
Last Price:
$62.92
Seasonality Move:
17.07%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight selling pressure.
Halozyme Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.07 | Sell |
| 20-day SMA: | 69.77 | Sell |
| 50-day SMA: | 68.67 | Sell |
| 200-day SMA: | 63.07 | Buy |
| 8-day EMA: | 68.67 | Sell |
| 20-day EMA: | 69.2 | Sell |
| 50-day EMA: | 68.89 | Sell |
| 200-day EMA: | 63.68 | Buy |
Halozyme Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 35.73 | Sell |
| Chaikin Money Flow: | -2511104 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Halozyme Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics, Inc. Stock
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 64.66 while HALO 8-day simple moving average is 70.07, which is a Sell signal.
-
The stock price of HALO is 64.66 while Halozyme Therapeutics, Inc. 20-day SMA is 69.77, which makes it a Sell.
-
Halozyme Therapeutics, Inc. 50-day simple moving average is 68.67 while HALO share price is 64.66, making it a Sell technically.
-
HALO stock price is 64.66 and Halozyme Therapeutics, Inc. 200-day simple moving average is 63.07, creating a Buy signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
66
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy or a Sell?
-
Halozyme Therapeutics, Inc. stock is rated a BuyThe current Halozyme Therapeutics, Inc. [HALO] share price is $64.66. The Score for HALO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics, Inc. Stock Info
Market Cap:
7.6B
Price in USD:
64.66
Share Volume:
2.9M
Halozyme Therapeutics, Inc. 52-Week Range
52-Week High:
79.50
52-Week Low:
46.26
Buy
66
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Halozyme Therapeutics, Inc. Share Price Forecast
-
What is the Halozyme Therapeutics, Inc. stock price today?The Halozyme Therapeutics, Inc. stock price is 64.66 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics, Inc. is not overvalued.
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 64.66 while HALO 8-day exponential moving average is 68.67, which is a Sell signal.
-
The stock price of HALO is 64.66 while Halozyme Therapeutics, Inc. 20-day EMA is 69.20, which makes it a Sell.
-
Halozyme Therapeutics, Inc. 50-day exponential moving average is 68.89 while HALO share price is 64.66, making it a Sell technically.
-
HALO stock price is 64.66 and Halozyme Therapeutics, Inc. 200-day simple moving average is 63.68, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics, Inc.
Is Halozyme Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and an increase next year of $1.83 per share.
Technical Analysis of Halozyme Therapeutics, Inc.
Should I short Halozyme Therapeutics, Inc. stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Halozyme Therapeutics, Inc. is a Sell
-
Halozyme Therapeutics, Inc. Relative Strength Index (RSI) is 35.73, which suggest Halozyme Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Halozyme Therapeutics, Inc. is ( - ), which suggest Halozyme Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Halozyme Therapeutics, Inc. is ( - ), which suggest Halozyme Therapeutics, Inc. is a Buy
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.